An Open-Label, Single Sequence, Three-Period Drug Interaction Study of GSK1349572 and Tipranavir/Ritonavir in Healthy Adult Subjects (ING113096).
Phase of Trial: Phase I
Latest Information Update: 24 Jan 2011
At a glance
- Drugs Dolutegravir; Ritonavir; Tipranavir
- Indications HIV infections; HIV-1 infections
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 24 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 10 Mar 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 20 Feb 2010 New trial record